The AIUR Trial: Surgical Gloves to Prevent Peripheral Neuropathy - Trial NCT05771974
Access comprehensive clinical trial information for NCT05771974 through Pure Global AI's free database. This phase not specified trial is sponsored by Young-Joon Kang and is currently Not yet recruiting. The study focuses on Chemotherapy-induced Peripheral Neuropathy. Target enrollment is 104 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Compression therapy using surgical gloves
Interventional
device
Sponsor & Location
Young-Joon Kang
Incheon St.Mary's Hospital
Timeline & Enrollment
N/A
May 01, 2023
Feb 01, 2026
Primary Outcome
Changes in the 11 items neurotoxicity component of the Functional Assessment of Cancer Therapy-Taxane (FACT-NTX) Therapy subscale
Summary
This study aims to demonstrate the preventive effect of compression therapy using surgical
 gloves in chemotherapy-induced peripheral neuropathy. Patient-reported outcome measures
 (PROMs) are utilized for comparing the change in neuropathic pain between intervention and
 control groups. Among the PROMs, the neurotoxicity component of the functional Assessment of
 Cancer Therapy-taxane (FACT-Tax) is used for good and poor outcomes between baseline and
 post-chemotherapy in paclitaxel-treated breast cancer patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05771974
Device Trial